Data in Lupus: Digital Therapeutic Improves Executive Function in Patients
Akili Interactive Labs, Inc. announced the publication of full data from a randomized, unblinded study that evaluated the ability of Akili’s digital therapeutic, AKL-T01, to improve cognitive dysfunction in patients diagnosed with Systemic Lupus Erythematosus (SLE). The study results showed significant improvement in motor and speed executive functions. Based on the results of this study, they are consistent with the cognitive improvements seen in other studies previously done outside of the company for patients with SLE after using digital therapeutic engine. AKL-T01 is delivered to patients through an interactive video game experience designed to target the neural systems that play a key role in attention function while using adaptive algorithms to personalize the treatment.
Read more about this news release here.
FDA issues de novo clearance for SonoMotion’s Stone Clear device, for kidney stone treatment
Stone Clear is the first and only device cleared by the FDA that uses external ultrasound pulses to facilitate passage of post-lithotripsy kidney stone fragments without surgery.
